Austria stands out due to its long-term reliable and stable conditions. These
features are particularly important for a research-based company such as
Boehringer Ingelheim. Furthermore, Vienna is a city with a good research
infrastructure and a high quality of life, and is thus also an interesting place
for highly qualified employees from Austria and abroad.
Boehringer Ingelheim was also present in Austria before the fall of the Iron Curtain and coordinates these activities from its Vienna base. Today Boehringer Ingelheim Regional Center Vienna (RCV) has 1,400 employees and is responsible for the pharmaceutical business and clinical research in more than 30 countries in Central and Eastern Europe and Central Asia. Its primary tasks are to build up and expand local organizations and structures, coordinate product launches and provide market support, plan and organize clinical research as well as to prepare specialized medical information and make it available.
In addition, Vienna serves as the company’s global cancer research center as well as one of its three sites for the research, development and production of biopharmaceuticals. Boehringer Ingelheim RCV currently ranks among the most important research-oriented pharmaceutical companies in the Austrian life sciences sector.
